CClinicalTrials.gg
CompletedNCT06221150Updated Feb 13, 2026

Bilateral Two Levels Serratus Anterior Plane Block in Pediatric Cardiac Surgery With Median Sternotomy

An interventional study of Bilateral two level serratus anterior block in Congenital Heart Disease, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 6 Months to 6 Years. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Cairo University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
6 Months to 6 Years
Sex
All
01

Study summary

The serratus anterior plane block (SAPB) is an anterolateral thoracic wall block that was described in 2013 by Blanco et al. who presented it as an alternative to other regional anesthetic techniques. It has been described in adults as an adjunct to general anesthesia or as a primary anesthetic technique for breast surgery, it has not been widely utilized as a primary anesthetic technique in the pediatric population. It was designed to block primarily the thoracic intercostal nerves and to provide complete analgesia of the lateral part of the thorax. It provides a viable alternative to paravertebral blockade and central neuraxial block in this patient population The investigators believe that the bilateral two-level injection technique may provide effective analgesia as its efficacy was not properly investigated in corrective heart surgeries with median sternotomy in the pediatric population.

02

Conditions studied

  • Congenital Heart Disease
03

In context

Heart Defects, Congenital

1,007 studies on the registry are indexed under Heart Defects, Congenital; 257 are open to participants now.

This study's enrollment of 48 is below the median of 60 across 524 interventional studies indexed under Heart Defects, Congenital.

Browse Heart Defects, Congenital studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Risk Adjustment for Congenital Heart Surgery (RACHS) category 1,2 and 3 Pediatric patients undergoing corrective congenital cardiac surgeries via a median sternotomy

Exclusion criteria

Exclusion Criteria:

  • Refusal of legal guardian.
  • Patient with congestive heart failure .
  • Patient undergoing Redo cardiac surgery.
  • Known allergy to local anesthetics.
  • Infection at injection site.
  • Bleeding disorders (drug induced i.e., coumadin; or genetic i.e. hemophilia; or acquired i.e. DIC), coagulopathy: PTT > 40 seconds, INR > 1.4, platelet count \< 100x10⁹.
  • severe renal impairment (estimated Glomerular filtration rate less than 30ml/min/1.73m2) or hepatic insufficiency (Child-Pugh Class B and C).
  • Neurological disorders because it will be difficult to assess their pain score (e.g. cerebral palsy).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    SAPB group

    bilateral two-level SAPB is performed with the guidance of ultrasound. While the patient is in the supine position with their arms abducted, the US probe is placed in longitudinal plane to visualize and count the ribs down from the clavicle while moving the transducer laterally and distally to identify the muscles overlying the 3rd and 6th ribs at the mid axillary line. Using in- plane approach, a 22-gauge short bevel needle is inserted and advanced to the plane deep to the serratus anterior muscle at the level of 3rd and 6th ribs bilaterally in succession over which a total volume of 1.5ml/kg bupivacaine 0.125% is divided and injected (0.75ml/kg on each side); with total dose not exceeding 2.5 mg/kg.

    Procedure: Bilateral two level serratus anterior block

  • No intervention
    control group

    Intraoperative fentanyl without nerve block

Interventions

  • ProcedureBilateral two level serratus anterior block

    bilateral two-level SAPB is performed with the guidance of ultrasound. While the patient is in the supine position with their arms abducted, the US probe is placed in longitudinal plane to visualize and count the ribs down from the clavicle while moving the transducer laterally and distally to identify the muscles overlying the 3rd and 6th ribs at the mid axillary line. Using in- plane approach, a 22-gauge short bevel needle is inserted and advanced to the plane deep to the serratus anterior muscle at the level of 3rd and 6th ribs bilaterally in succession over which a total volume of 1.5ml/kg bupivacaine 0.125% is divided and injected (0.75ml/kg on each side); with total dose not exceeding 2.5 mg/kg.

    Also known as: Bilateral SAPB

06

What researchers measure

Primary outcomes

  1. Postoperative Fentanyl consumption

    Time frame: in the first 24 hours post-operatively

Secondary outcomes

  1. intraoperative heart rate

    After induction of anesthesia (baseline), after skin incision, after sternotomy, during aortic cannulation, and 15 minutes after weaning from cardiopulmonary bypass

    Time frame: Intraoperative period

  2. Intraoperative systolic blood pressure

    After induction of anesthesia (baseline), after skin incision, after sternotomy, during aortic cannulation, and 15 minutes after weaning from cardiopulmonary bypass

    Time frame: Intraoperative period

  3. Intraoperative additional boluses of fentanyl

    additional boluses of fentanyl at a dose of 0.5 µg/kg whenever HR or SBP increased more than 20% of baseline

    Time frame: Intraoperative period

  4. Postoperative heart rate

    Time frame: at 1, 2, 4, 8, 12, and 24 hours post-operatively

  5. Postoperative systolic blood pressure

    Time frame: at 1, 2, 4, 8, 12, and 24 hours post-operatively

  6. Postoperative Face, Leg, Activity, Cry, Consolability "FLACC" pain scale

    Postoperative pain intensity measured by FLACC scale in children. The score ranges from 0 to 10, where 0 indicates no pain, 1-3 mild discomfort, 4-6 moderate pain, and 7-10 severe pain/discomfort.

    Time frame: at 1, 2, 4, 8, 12, and 24 hours post-operatively

  7. Time to first rescue analgesia

    first incidence of fentanyl bolus in the postoperative phase if FLACC score is 4 or more, targeting FLACC score of 3 or less

    Time frame: recorded during the first 24 hours after surgery (in hours unit)

  8. Time to extubation

    Either within 2, 6, 12, or 24 hours after surgery

    Time frame: 24 hours post-operatively

  9. Incidence of complications

    Complications including postoperative vomiting, hematoma formation, ithching, or local anesthetic toxicity

    Time frame: 24 hours post-operatively

07

Study locations

1 site
  • Abu El Reesh pediatric university hospital
    Cairo, Egypt
08

References and documents

Publications

  • Mayes J, Davison E, Panahi P, Patten D, Eljelani F, Womack J, Varma M. An anatomical evaluation of the serratus anterior plane block. Anaesthesia. 2016 Sep;71(9):1064-9. doi: 10.1111/anae.13549. Epub 2016 Jul 20. PubMed 27440171 ↗
  • Ren Y, Li L, Gao J, Hua L, Zheng T, Wang F, Zhang J. Regional Analgesia in Pediatric Cardiothoracic Surgery: A Bayesian Network Meta-Analysis. J Cardiothorac Vasc Anesth. 2025 Apr;39(4):1037-1048. doi: 10.1053/j.jvca.2024.12.043. Epub 2025 Jan 9. PubMed 39880711 ↗
  • Egbuta C, Mason KP. Current State of Analgesia and Sedation in the Pediatric Intensive Care Unit. J Clin Med. 2021 Apr 23;10(9):1847. doi: 10.3390/jcm10091847. PubMed 33922824 ↗
  • Mazzeffi M, Khelemsky Y. Poststernotomy pain: a clinical review. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1163-78. doi: 10.1053/j.jvca.2011.08.001. Epub 2011 Sep 29. No abstract available. PubMed 21955825 ↗
  • Shenkman Z, Shir Y, Weiss YG, Bleiberg B, Gross D. The effects of cardiac surgery on early and late pulmonary functions. Acta Anaesthesiol Scand. 1997 Oct;41(9):1193-9. doi: 10.1111/j.1399-6576.1997.tb04865.x. PubMed 9366943 ↗
  • Sasseron AB, Figueiredo LC, Trova K, Cardoso AL, Lima NM, Olmos SC, Petrucci O. Does the pain disturb the respiratory function after open heart surgery? Rev Bras Cir Cardiovasc. 2009 Oct-Dec;24(4):490-6. doi: 10.1590/s0102-76382009000500010. English, Portuguese. PubMed 20305922 ↗
  • Ergun A, Sirlak M. [Pulmonary function test before and after operation of coronary artery by-pass surgery]. Tuberk Toraks. 2003;51(1):17-22. Turkish. PubMed 15100899 ↗
  • Zubrzycki M, Liebold A, Skrabal C, Reinelt H, Ziegler M, Perdas E, Zubrzycka M. Assessment and pathophysiology of pain in cardiac surgery. J Pain Res. 2018 Aug 24;11:1599-1611. doi: 10.2147/JPR.S162067. eCollection 2018. PubMed 30197534 ↗
  • Guimaraes-Pereira L, Reis P, Abelha F, Azevedo LF, Castro-Lopes JM. Persistent postoperative pain after cardiac surgery: a systematic review with meta-analysis regarding incidence and pain intensity. Pain. 2017 Oct;158(10):1869-1885. doi: 10.1097/j.pain.0000000000000997. PubMed 28767509 ↗
  • He Y, Xu M, Li Z, Deng L, Kang Y, Zuo Y. Safety and feasibility of ultrasound-guided serratus anterior plane block and intercostal nerve block for management of post-sternotomy pain in pediatric cardiac patients: A prospective, randomized trial. Anaesth Crit Care Pain Med. 2023 Dec;42(6):101268. doi: 10.1016/j.accpm.2023.101268. Epub 2023 Jun 24. PubMed 37364851 ↗
  • Kupeli I, Adilovic AS. The "Feasibility" And "Safety" Of Ultrasound Guided Bilateral Two Level Serratus Anterior Plane Block in Children With Median Sternotomy Pain: A Case Series. J Cardiothorac Vasc Anesth. 2021 Jan;35(1):270-273. doi: 10.1053/j.jvca.2020.03.020. Epub 2020 Mar 19. No abstract available. PubMed 32360008 ↗
  • Abdelbaser II, Mageed NA. Analgesic efficacy of ultrasound guided bilateral transversus thoracis muscle plane block in pediatric cardiac surgery: a randomized, double-blind, controlled study. J Clin Anesth. 2020 Dec;67:110002. doi: 10.1016/j.jclinane.2020.110002. Epub 2020 Jul 24. PubMed 32717448 ↗
  • Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR. The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth. 2006 Mar;16(3):258-65. doi: 10.1111/j.1460-9592.2005.01773.x. PubMed 16490089 ↗
  • Voepel-Lewis T, Zanotti J, Dammeyer JA, Merkel S. Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients. Am J Crit Care. 2010 Jan;19(1):55-61; quiz 62. doi: 10.4037/ajcc2010624. PubMed 20045849 ↗
  • Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997 May-Jun;23(3):293-7. PubMed 9220806 ↗
  • Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7. PubMed 23923989 ↗
  • Tewari P, Hajela K, Ahmad SS. Bilateral superficial serratus anterior plane block in a pediatric patient for post-operative analgesia undergoing asd repair via median sternotomy- A case report. Ann Card Anaesth. 2022 Jan-Mar;25(1):116-118. doi: 10.4103/aca.aca_113_21. PubMed 35075035 ↗
  • Devarajan J, Balasubramanian S, Shariat AN, Bhatt HV. Regional Analgesia for Cardiac Surgery. Part 2: Peripheral Regional Analgesia for Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2021 Dec;25(4):265-279. doi: 10.1177/10892532211002382. Epub 2021 Apr 8. PubMed 33827348 ↗
  • Jack JM, McLellan E, Versyck B, Englesakis MF, Chin KJ. The role of serratus anterior plane and pectoral nerves blocks in cardiac surgery, thoracic surgery and trauma: a qualitative systematic review. Anaesthesia. 2020 Oct;75(10):1372-1385. doi: 10.1111/anae.15000. Epub 2020 Feb 16. PubMed 32062870 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06221150
Lead sponsor
Cairo University
Responsible party
Mai Madkour (Associate professor, Cairo University) — Principal investigator
First posted
Jan 24, 2024
Start date
Jan 20, 2025
Primary completion
Jan 30, 2026
Completion
Jan 30, 2026
Last update
Feb 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion